Unknown

Dataset Information

Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine.


ABSTRACT:

Purpose

The outbreak of coronavirus disease 2019 (COVID-19) has caused many children to stay indoors. Increased near work and insufficient outdoor activities are considered important risk factors for myopic progression. This study aimed to compare the changes in myopic progression before and after COVID-19 in children treated with low-concentration atropine.

Methods

The records of 103 eyes of 103 children who were treated with low-concentration atropine eye drops were retrospectively reviewed. We classified children according to the concentration of atropine eye drops and children's age. The beginning of the pre-COVID-19 period was set from January 2019 to May 2019, and the endpoint was set in March 2020. The beginning of the post-COVID-19 period was set in March 2020, and t

SUBMITTER: Yum HR 

PROVIDER: S-EPMC8439482 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature